$VKTX, $GPCR, $RYTM, $ACIU, $VYGR, $KRTX, $ITCI, $PRQR, $ARWR, $ALNY, and more...
Bullish trends & names to watch for in the biotech market
2023 has already brought several high-profile M&A deals, as pharma giants are sitting on an estimated $272B of cash and looking to spend it. As we wrote last week, M&A deals are on pace to hit a record in 2023 (read here), showing that biotech valuations are nearing a reasonable level. The largest deals of the year so far include Pfizer agreeing to acqu…